Pressure BioSciences, Inc.
375 West Street
299 articles with Pressure BioSciences, Inc.
Pressure BioSciences, Inc. today reported continued strong financial results for the second quarter ended June 30, 2021, provided a business update, and offered guidance for the remainder of FY 2021.
Pressure BioSciences to Host Q2 2021 Financial Results and Business Update on Thursday, August 19, 2021
Pressure BioSciences, Inc. today announced that the Company will host a teleconference to discuss its Second Quarter 2021 financial results and provide a business update.
Pressure BioSciences New Eco-Friendly Agrochem Subsidiary Receives Over $1,000,000 in Orders in First Month of Operations
Pressure BioSciences, Inc. today announced that its newly-formed agrochemicals subsidiary - PBI Agrochem, Inc. - has received initial purchase orders for over $1M of eco-friendly agrochemical products for delivery in 2021.
Pressure BioSciences Unveils Aggressive Growth Plan and Goals for Second Half 2021; Company Marches Toward UST Commercial Release, Up-listing, and Profitability
Pressure BioSciences, Inc. today announced major aggressive goals for the second half of 2021.
Pressure BioSciences Announces Major Business Expansion, Establishing Eco-Friendly Agrochemicals Subsidiary and Initiating Plans to Drive Accretive 2021 Revenue
Pressure BioSciences, Inc. today announced it has established a wholly-owned agrochemicals subsidiary named PBI Agrochem, Inc.
Pressure BioSciences Novel UST Platform Delivers Breakthrough Nanoemulsion Processing for One of the World's Most Potent Antioxidants - Astaxanthin
Pressure BioSciences, Inc. today announced the application of its Ultra Shear Technology™ ("UST™") platform for the development of more potent formulations of wide-ranging nutraceuticals of high therapeutic value, allowing for more controlled dosing and opportunities for lower cost solutions for both manufacturers and consumers.
Company Invites Individual and Institutional Investors, as well as Analysts and Advisors, to Attend Its Real-Time, Interactive Presentation on Wednesday, June 23, 2021
Company Invites Individual and Institutional Investors, as well as Advisors and Analysts, to Attend the Company's Virtual Presentation on Thursday, June 10, 2021.
Pressure BioSciences, Inc. Reports Resurgent Growth with Strong First Quarter 2021 Financial Results and Provides Business Update
Significant Growth Reported in Total Revenue (121%), Instrument Sales (235%), and Consumable Products (81%); Definitive Progress Continued in the BaroFold and UST Platforms; Closure Expected Soon on Agrochemical Supplier Asset Acquisition Investor Conference Call Scheduled for Wednesday, May 19, 2021 at 4:30 p.m. EDT
With Sales Up Over 120%, Pressure BioSciences to Host Q1 2021 Financial Results and Business Update on Wednesday, May 19, 2021
Q1 Financial Results Strongest Since Q4 2018; Q2 Revenue Already Exceeds Q2 2020. Purchase of Accretive, Eco-Friendly Agrochemical Supplier Nearing Close.
Pressure BioSciences Awarded Three Additional Patents for Revolutionary Ultra Shear Technology Platform
Unique Commercial-Scale Capabilities for Highest-Quality Nanoemulsions of Oils in Water Enabled by PBI's UST Platform, Addressing Multiple Billion Dollar Opportunities in Diverse Markets Worldwide
Pressure BioSciences, Inc. to Discuss Fourth Quarter and Fiscal Year 2020 Financial Results and Provide Business Update
Pressure BioSciences, Inc. (OTCQB: PBIO) today announced that the Company will host a teleconference to discuss its Fourth Quarter and Fiscal Year 2020 financial results and to provide a business update. Anyone interested may listen to the teleconference either live (by telephone) or through a replay
Company Expects Acquisition to be Accretive with Sustained Profitable Revenue Growth, Leveraging Market-Changing Synergy from PBIs Ultra Shear Technology Nanoemulsions Platform
Transformative Impact for Food Industry Consortium Formed by Pressure BioSciences and The Ohio State University Discussed in Showcase Video from Emerging Technology Insider
Interview of PBIO CEO Ric Schumacher Focuses on Potential Impact of Company's Innovative UST Platform for Major Advances in Food Safety, Clean Label, Nutrition, and Long-Term Room Temperature Stability
Pressure BioSciences and The Ohio State University Announce Food Industry Consortium to Advance Commercialization of PBI's Ultra Shear Technology
Academia-Industry Partnership to Support Improvements in UST Applications and Allow Global Food Companies Access to UST for Preparation of Safer, More Nutritious Liquid Foods and Beverages [24-February-2021] SOUTH EASTON, Mass. , Feb. 24, 2021 /PRNewswire/ --Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broa
PBI's Ultra Shear Technology for Nanoemulsion Processing Targets New Generation of High Performance, "Green" Agrochemicals for Worldwide Distribution into Food Production Markets
Pressure BioSciences Ultra Shear Technology Nanoemulsions Platform Targets Revolution in Effectiveness of Therapeutics via Improved Drug Delivery and Dosing Safety
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology services to the worldwide biotechnology, biotherapeutics, and other industries, today announced a collaboration with SinuSys Corporation
Pressure BioSciences PCT Platform at Forefront in Generating Pivotal Findings by Diverse COVID-19 Research Teams in USA, China, and Europe
PCT's Effectiveness and Reproducibility Impacts Research Results and Fills Critical Role in Achieving Important Insights for the Development of New and Improved COVID-19 Diagnostics and Therapeutics [17-December-2020] SOUTH EASTON, Mass. , Dec. 17, 2020 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and s
Company Invites Individual and Institutional Investors, as well as Advisors and Analysts, to Attend Live, Interactive Presentations on Thursday, December 17, 2020
Pressure BioSciences Proposed Acquisition Partner Cannaworx, Inc. Announces December 2020 Launch Date for FDA Registered Immune Booster
Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions to the worldwide biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food & beverage industries, today announced that its proposed acquisition partner Cannaworx, Inc. has set December 2020